Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Chugai Withdraws from Medical Devices to Concentrate on Drug Business
December 10, 2001
- Kyorin to Codevelop Nail Lacquer with Maruho
December 10, 2001
- Ryukinkyo-like Discussion Forum Is Necessary: FJPWA President
December 10, 2001
- Taisho, Tanabe Cancel Their Integration
December 10, 2001
- REGULATORY NEWS IN BRIEF
December 10, 2001
- Fujisawa Hopes to Become Global Megaplayer by 2010: President Aoki
December 10, 2001
- Questions Raised Regarding NHI Prices of Interferons
December 10, 2001
- Ohki: Sales Up 2.7%, Operating Profits Up 22.0%
December 10, 2001
- Sales of 4 New Drugs Including Advaferon, Palmicort Expected to Exceed \10 Bil.
December 10, 2001
- DIAGNOSTIC NEWS IN BRIEF
December 10, 2001
- 9 NCEs Including Glivec, Rebetol Listed
December 10, 2001
- MEDICAL DEVICE NEWS IN BRIEF
December 10, 2001
- Korosho to Regard Original Products without Generics as Long-listed
December 10, 2001
- Shimadzu: New Electronic Medical Chart System
December 10, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
December 10, 2001
- WORLD NEWS IN BRIEF
December 10, 2001
- Vital-Net: Operating Profits Drop Despite Big Increases in Sales
December 10, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
December 10, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -2-
December 10, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -1-
December 10, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…